EPISODE · Mar 27, 2017 · 15 MIN
John Poss, CEO of GB Sciences, Explains Their Methodical Approach to the Study and Cultivation of Medical Cannabis
from Stock Day Media · host Stock Day Media
Jasyn Blair Interviews John Poss, CEO for GB Sciences, Inc. (GBLX), and they discuss using their process in cultivating and extracting for the use of Cannabis for medicinal Purposes. -- Visit http://UptickNewswire.com for more Interviews and the latest penny stock news -- We are pleased to share the following UPTICK Network Stock Day Radio Show and Podcast content. The CEOs interviewed on Stock Day did not incur any charges for their time with Uptick CEO Everett Jolly. Uptick staff is always looking for exciting companies to bring to our interested readers and listeners. Contact us at (602) 441-3474 if you would like further information on the UPTICK Network or Uptick services. Advertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy
What this episode covers
Jasyn Blair Interviews John Poss, CEO for GB Sciences, Inc. (GBLX), and they discuss using their process in cultivating and extracting for the use of Cannabis for medicinal Purposes. -- Visit http://UptickNewswire.com for more Interviews and the latest penny stock news -- We are pleased to share the following UPTICK Network Stock Day Radio Show and Podcast content. The CEOs interviewed on Stock Day did not incur any charges for their time with Uptick CEO Everett Jolly. Uptick staff is always looking for exciting companies to bring to our interested readers and listeners. Contact us at (602) 441-3474 if you would like further information on the UPTICK Network or Uptick services. Advertising Inquiries: https://redcircle.com/brands Privacy & Opt-Out: https://redcircle.com/privacy
NOW PLAYING
John Poss, CEO of GB Sciences, Explains Their Methodical Approach to the Study and Cultivation of Medical Cannabis
No transcript for this episode yet
Similar Episodes
Sep 22, 2023 ·20m
Sep 22, 2023 ·20m
Sep 22, 2023 ·27m
Sep 22, 2023 ·14m
Sep 22, 2023 ·24m
Sep 22, 2023 ·22m